The expanding class of drugs known as GLP-1 receptor activators are impacting metabolic treatment, but the delivery method is emerging as a key decision. Initially , these powerful medications were offered solely in pill form. However, new transdermal systems are now being introduced, prompting many patients to ask which option is preferable. Consi